CRISPR Therapeutics AG (CRSP)
43.85
-0.50 (-1.13%)
USD |
NASDAQ |
Mar 28, 16:00
44.15
+0.30 (+0.68%)
After-Hours: 20:00
CRISPR Therapeutics Revenue (TTM): 0.436M for Dec. 31, 2022
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.436M |
| September 30, 2022 | 12.78M |
| June 30, 2022 | 13.01M |
| March 31, 2022 | 913.06M |
| December 31, 2021 | 913.08M |
| September 30, 2021 | 900.93M |
| June 30, 2021 | 900.75M |
| March 31, 2021 | 0.588M |
| December 31, 2020 | 0.543M |
| September 30, 2020 | 77.36M |
| June 30, 2020 | 289.14M |
| March 31, 2020 | 289.42M |
| December 31, 2019 | 289.59M |
| Date | Value |
|---|---|
| September 30, 2019 | 212.69M |
| June 30, 2019 | 1.324M |
| March 31, 2019 | 2.094M |
| December 31, 2018 | 3.124M |
| September 30, 2018 | 35.33M |
| June 30, 2018 | 37.16M |
| March 31, 2018 | 39.65M |
| December 31, 2017 | 41.00M |
| September 30, 2017 | 11.02M |
| June 30, 2017 | 10.18M |
| March 31, 2017 | 7.391M |
| December 31, 2016 | 5.164M |
| September 30, 2016 | 3.067M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.436M
Minimum
Dec 2022
913.08M
Maximum
Dec 2021
246.60M
Average
38.40M
Median
Revenue (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | 8.931B |
| Intellia Therapeutics Inc | 52.12M |
| Beam Therapeutics Inc | 60.92M |
| Moderna Inc | 18.88B |
| Editas Medicine Inc | 19.71M |